1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,990 | 1,080 | 17.04. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 14.04. | DMS GROUP: DMS Group: ANNUAL RESULTS 2024 - SUSTAINED GROWTH SIGNIFICANT IMPROVEMENT OF OPERATIONAL PROFITABILITY - CONFIRMATION OF THE IMAGING 2027 PLAN | 209 | Actusnews Wire | 2024 revenue with continuous growth: €46.1 million, up 9%
Significant improvement in EBITDA: +57%
Significant reduction in operational costs and overhead costs from the 2nd half of the year
Confirmation... ► Artikel lesen | |
| 07.03. | DMS GROUP: DMS Group Selected by Ukrainian Authorities for the Delivery of 120 Emergency Mobile Radiology Units in a Contract Worth EUR 11M | 396 | Actusnews Wire | March 7, 2025 - 10:00 AM - Diagnostic Medical Systems (Euronext Growth Paris: FR0012202497 - ALDMS and FR001400IAQ8 - DMSBS), a specialist in high-performance medical imaging systems for Digital... ► Artikel lesen | |
| DIAGNOSTIC MEDICAL SYSTEMS Aktie jetzt für 0€ handeln | |||||
| 25.02. | DMS GROUP PRESENTS ITS MAJOR INNOVATIONS AT THE 2025 EUROPEAN CONGRESS OF RADIOLOGY (ECR) | 370 | Actusnews Wire | 25 February 2025 - 18:00 - Diagnostic Medical Systems (Euronext Growth Paris: FR0012202497 - ALDMS et FR001400IAQ8 - DMSBS), a specialist in high-performance medical imaging systems for digital... ► Artikel lesen | |
| 16.01. | DMS GROUP: ANOTHER YEAR OF DYNAMIC GROWTH | 358 | Actusnews Wire | Expansion of the product range and development of new solutions
Strong growth expected in 2025
Focus on Imaging 2027!
€46 M
Revenue
9%
Revenue growth vs 2023
January 16, 2025... ► Artikel lesen | |
| 20.12.24 | DMS GROUP: Verso Capital increases its Stake in DMS Group | 793 | Actusnews Wire | December 20, 2024 - 6:00 PM - Diagnostic Medical Systems Group (Euronext Growth Paris: FR0012202497 - ALDMS et FR001400IAQ8 - DMSBS), a specialist in high-performance digital medical imaging systems... ► Artikel lesen |
5 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BIOTEST | 30,200 | 0,00 % | Westbourne River Partners letter to Biotest AG | LONDON, April 15, 2025 /PRNewswire/ -- Westbourne River Partners letter to Biotest AG with respect to the delisting offer made by Grifols S.A. to shareholders of Biotest:
Biotest AGAttn.... ► Artikel lesen | |
| CROSS COUNTRY HEALTHCARE | 12,400 | 0,00 % | CROSS COUNTRY HEALTHCARE INC - 10-K/A, Annual Report | ||
| PROCEPT BIOROBOTICS | 53,10 | +0,13 % | Piper Sandler maintains $100 target on Procept BioRobotics stock | ||
| GENEDX | 88,80 | -6,99 % | Secure and explainable: Sema4.ai enables AI agents for widespread enterprise deployment | ||
| ALIGNMENT HEALTHCARE | 17,440 | -4,39 % | Alignment Healthcare, Inc. - 8-K, Current Report | ||
| NUTEX HEALTH | 148,00 | -0,67 % | Nutex Health files prospectus for secondary offering | ||
| CASTLE BIOSCIENCES | 21,620 | +0,51 % | Castle Biosciences Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Results | FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced certain unaudited preliminary... ► Artikel lesen | |
| ADAPTHEALTH | 7,325 | -5,97 % | AdaptHealth Corp. Announces Third Quarter 2024 Results | PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including... ► Artikel lesen | |
| AGILON HEALTH | 4,185 | +4,49 % | Where Agilon Health Stands With Analysts | ||
| BRIGHTSPRING HEALTH SERVICES | 15,560 | -6,27 % | BrightSpring Health Services, Inc. TANGIBLE EQUITY UNIT declares $0.843 dividend | ||
| PRIVIA HEALTH GROUP | 22,830 | -3,59 % | Assessing Privia Health Gr: Insights From 10 Financial Analysts | ||
| RESHAPE LIFESCIENCES | 0,432 | +39,59 % | ReShape Lifesciences skyrockets after receiving U.S. patent for diabetes neuromodulation technology | ||
| PROGYNY | 20,895 | -2,54 % | Progyny, Inc.: Progyny Names Healthcare Veterans Melissa Cummings as Chief Operating Officer and Geoffrey Clapp as Chief Product Officer | NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- Progyny (Nasdaq: PGNY), a global leader in women's health and family building, today announced the appointments of Melissa Cummings as the company's first... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 6,215 | -7,24 % | LifeStance Health Group, Inc.: LifeStance Reports Fourth Quarter and Full Year 2024 Results | SCOTTSDALE, Ariz., Feb. 27, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| CERIBELL | 14,850 | +0,03 % | CBLL Stock Falls Despite FDA Clearance for Pediatric Clarity Algorithm |
Das Unternehmen DIAGNOSTIC MEDICAL SYSTEMS SA kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 0,936 Euro und damit -1,06 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu DIAGNOSTIC MEDICAL SYSTEMS SA finden Sie auf Wallstreet Online.
